OGSIVEO

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Nov 27, 2023

   2 yr 7 mo ago

2. Today

3. Exclusivity ends · NCE

   New chemical entity exclusivity (5 years)

   Nov 27, 2028

   in 2 yr 6 mo

4. Patent 7795447 expires

   Listed drug substance patent expiration.

   Aug 18, 2030

   in 4 yr 3 mo

5. Exclusivity ends · ODE-452

   Orphan-drug exclusivity (7 years)

   Nov 27, 2030

   in 4 yr 6 mo

6. Patent 10590087 expires

   Listed drug substance patent expiration.

   Aug 09, 2039

   in 13 yr 4 mo

7. Patent 10710966 expires

   Listed drug substance patent expiration.

   Aug 09, 2039

   in 13 yr 4 mo

8. Patent 10941118 expires

   Listed drug substance patent expiration.

   Aug 09, 2039

   in 13 yr 4 mo

9. Patent 11820748 expires

   Listed drug product patent expiration.

   Aug 09, 2039

   in 13 yr 4 mo

10. Patent 11845732 expires

    Listed drug substance patent expiration.

    Aug 09, 2039

    in 13 yr 4 mo

11. Patent 11884634 expires

    Listed drug product patent expiration.

    Aug 09, 2039

    in 13 yr 4 mo

12. Patent 11884635 expires

    Listed drug product patent expiration.

    Aug 09, 2039

    in 13 yr 4 mo

13. Patent 11905255 expires

    Listed drug product patent expiration.

    Aug 09, 2039

    in 13 yr 4 mo

14. Patent 12116347 expires

    Listed drug product patent expiration.

    Aug 09, 2039

    in 13 yr 4 mo

15. Patent 12297177 expires

    Listed drug product patent expiration.

    Aug 09, 2039

    in 13 yr 4 mo

16. Patent 11504354 expires

    Listed drug product patent expiration.

    Jul 08, 2042

    in 16 yr 3 mo

17. Patent 11612588 expires

    Listed drug product patent expiration.

    Jul 08, 2042

    in 16 yr 3 mo

18. Patent 12110277 expires

    Listed drug product patent expiration.

    Jul 08, 2042

    in 16 yr 3 mo

19. Patent 12234210 expires

    Listed drug product patent expiration.

    Jul 08, 2042

    in 16 yr 3 mo

20. Patent 12247012 expires

    Listed drug product patent expiration.

    Jul 08, 2042

    in 16 yr 3 mo

21. Patent 12599587 expires

    Listed drug product patent expiration.

    Jul 08, 2042

    in 16 yr 3 mo

22. Patent 11807611 expires

    Listed drug product patent expiration.

    Sep 08, 2042

    in 16 yr 6 mo

23. Patent 11844780 expires

    Listed drug product patent expiration.

    Sep 08, 2042

    in 16 yr 6 mo

24. Patent 11872211 expires

    Listed method-of-use patent (U-3754) expiration.

    May 19, 2043

    in 17 yr 2 mo

25. Patent 11925619 expires

    Listed method-of-use patent (U-3754) expiration.

    May 19, 2043

    in 17 yr 2 mo

26. Patent 11925620 expires

    Listed method-of-use patent (U-3754) expiration.

    May 19, 2043

    in 17 yr 2 mo

27. Patent 11938116 expires

    Listed method-of-use patent (U-3754) expiration.

    May 19, 2043

    in 17 yr 2 mo

28. Patent 11951096 expires

    Listed method-of-use patent (U-3754) expiration.

    May 19, 2043

    in 17 yr 2 mo

29. Patent 11957662 expires

    Listed method-of-use patent (U-3754) expiration.

    May 19, 2043

    in 17 yr 2 mo

30. Patent 12011434 expires

    Listed method-of-use patent (U-3754) expiration.

    May 19, 2043

    in 17 yr 2 mo

31. Patent 12011435 expires

    Listed method-of-use patent (U-3754) expiration.

    May 19, 2043

    in 17 yr 2 mo

32. Patent 12036207 expires

    Listed method-of-use patent (U-3754) expiration.

    May 19, 2043

    in 17 yr 2 mo

33. Patent 12138246 expires

    Listed method-of-use patent (U-3754) expiration.

    May 19, 2043

    in 17 yr 2 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (2)

• NCENew chemical entity exclusivity (5 years)

  Nov 27, 2028

  in 2 yr 6 mo

• ODE-452Orphan-drug exclusivity (7 years)

  Nov 27, 2030

  in 4 yr 6 mo

Listed patents (29)